Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Suzetrigine (Journavx) in Spine Surgery: Signal Characterization and Trial-Design Optimization Using Historical Controls

NCT07829718 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT07829718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07829718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Suzetrigine (Journavx) in Spine Surgery: Signal Characterization and Trial-Design Optimization Using Historical Controls
Lead sponsor
Ohio State University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 13, 2026
Completion date
December 30, 2030
Enrollment
110 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain, spine fusion